Objective: Evaluation of the effects of camel milk compared with cow milk intake on glucose and insulin concentrations in patients with type 2 diabetes.
Design: Randomized, Single blind
Setting and conduct:
A- Participants including major eligibility criteria
- Major inclusion criteria: Patients with type 2 diabetes
- Major exclusion criteria: Insulin ihjection and having cardiovascular and renal diseases
- Sample size: 40
B- Intervention: 500 cc camel or caw milk
C- Intervention Time: Evaluation of changes in glucose and insulin concentrations in 15, 30, 60, 120, and 180 minutes after consuming milk
D- Main outcome: Blood sugar and insulin
General information
Acronym
IRCT registration information
IRCT registration number:IRCT201302024794N6
Registration date:2013-02-18, 1391/11/30
Registration timing:registered_while_recruiting
Last update:
Update count:0
Registration date
2013-02-18, 1391/11/30
Registrant information
Name
Fereidoun Azizi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2240 9309
Email address
azizi@endocrine.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice chancellor for Research Institute for Endocrine Science, Shahid Beheshti University of Medical Sciences
Expected recruitment start date
2012-12-21, 1391/10/01
Expected recruitment end date
2013-08-21, 1392/05/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of changes in serum glucose and insulin concentrations following camel milk intake in type 2 diabetic patients
Public title
camel milk and changes in serum glucose
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion Criteria: Patients with type 2 diabetes; age range: 20 to 70 years old; treatment with diet or oral anti-diabetic drugs. Exclusion Criteria: Treatment with insulin; pregnancy or lactation; smoking and alcohol consumption; body mass index greater than 35 kg/m2 ; Lactose intolerance; taking estrogenic drugs and corticosteroids; having cardiovascular disease, liver, lung, kidney and Chronic gastrointestinal and thyroid dysfunction; following from the weight loss diets two months prior to study; weight changes (increase or decrease) more than 5 kg two months prior to study.
Age
From 20 years old to 70 years old
Gender
Both
Phase
2-3
Groups that have been masked
No information
Sample size
Target sample size:
40
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Single blinded
Blinding description
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee, Research Institute For Endocrine Sciences, Shahid Beheshti University of Medical S